Sun Pharmaceutical Industries Limited (BOM:524715)
India · Delayed Price · Currency is INR 1,758.00
-2.00 (-0.11%)
At close: Oct 28, 2026
BOM:524715 Stock Forecast
Stock Price Forecast
According to 33 analysts polled by S&P Global, BOM:524715 stock has a consensus rating of "Buy" and an average price target of ₹2,174. The average 1-year stock price forecast is 23.68% higher than the current stock price, while the lowest is ₹1,830 (+4.10%) and the highest is ₹2,400 (+36.52%).
Price Target: ₹2,174 (+23.68%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for BOM:524715 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 20 | 20 | 20 | 19 | 18 | 18 |
| Buy | 10 | 10 | 10 | 10 | 10 | 10 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 2 | 2 | 2 | 3 | 3 | 3 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 34 | 34 | 34 | 34 | 33 | 33 |
Financial Forecast
Revenue This Year
651.00B
from 584.62B
Increased by 11.35%
Revenue Next Year
729.57B
from 651.00B
Increased by 12.07%
EPS This Year
54.68
from 52.01
Increased by 5.13%
EPS Next Year
64.97
from 54.68
Increased by 18.82%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.